Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin Ding

Showing results (501-510 of 545) with videos related to

Pageof 55
Sort By:
Cancer Cell|May 18, 2011
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesisEmilie A Bard-Chapeau, Shuangwei Li, Jin Ding, et al.
Signal Transduction and Targeted Therapy|December 28, 2020
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistanceTengfei Zhou, Shichao Li, Daimin Xiang, et al.
Cell Death & Disease|February 3, 2024
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancerYunong Xie, Haofeng Wu, Yimiao He, et al.
Hepatology (Baltimore, Md.)|August 18, 2012
Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentKun Wu, Jin Ding, Cheng Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 3, 2019
Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysisXiu-Ping Zhang, Zong-Tao Chai, Yu-Zhen Gao, et al.
Theranostics|May 28, 2019
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4αBai-Nan Zheng, Chen-Hong Ding, Shi-Jie Chen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cellsZhipeng Wang, Jiao Tan, Christopher McConville, et al.
Gut|November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagyWen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Journal of Clinical Gastroenterology|December 12, 2022
Effect of Premedication With Pronase Before Upper Gastrointestinal Endoscopy: A Multicenter Prospective Randomized Controlled StudyJun Li, Lan Wang, Weiling Hu, et al.
ACS Pharmacology & Translational Science|June 20, 2024
Preclinical Evaluation and Pilot Clinical Study of <sup>18</sup>F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2Jin Ding, Qian Zhang, Jinquan Jiang, et al.
Pageof 55

Showing results (501-510 of 545) with videos related to

Sort By:
Pageof 55
Cancer Cell|May 18, 2011
Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesisEmilie A Bard-Chapeau, Shuangwei Li, Jin Ding, et al.
Signal Transduction and Targeted Therapy|December 28, 2020
m6A RNA methylation-mediated HNF3γ reduction renders hepatocellular carcinoma dedifferentiation and sorafenib resistanceTengfei Zhou, Shichao Li, Daimin Xiang, et al.
Cell Death & Disease|February 3, 2024
Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancerYunong Xie, Haofeng Wu, Yimiao He, et al.
Hepatology (Baltimore, Md.)|August 18, 2012
Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer developmentKun Wu, Jin Ding, Cheng Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|June 3, 2019
Postoperative adjuvant sorafenib improves survival outcomes in hepatocellular carcinoma patients with microvascular invasion after R0 liver resection: a propensity score matching analysisXiu-Ping Zhang, Zong-Tao Chai, Yu-Zhen Gao, et al.
Theranostics|May 28, 2019
Targeting PRMT5 Activity Inhibits the Malignancy of Hepatocellular Carcinoma by Promoting the Transcription of HNF4αBai-Nan Zheng, Chen-Hong Ding, Shi-Jie Chen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|August 14, 2016
Poly lactic-co-glycolic acid controlled delivery of disulfiram to target liver cancer stem-like cellsZhipeng Wang, Jiao Tan, Christopher McConville, et al.
Gut|November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagyWen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Journal of Clinical Gastroenterology|December 12, 2022
Effect of Premedication With Pronase Before Upper Gastrointestinal Endoscopy: A Multicenter Prospective Randomized Controlled StudyJun Li, Lan Wang, Weiling Hu, et al.
ACS Pharmacology & Translational Science|June 20, 2024
Preclinical Evaluation and Pilot Clinical Study of <sup>18</sup>F-Labeled Inhibitor Peptide for Noninvasive Positron Emission Tomography Mapping of Angiotensin Converting Enzyme 2Jin Ding, Qian Zhang, Jinquan Jiang, et al.
Pageof 55